Portefølje

Aktiv portefølje (31.12.09) Eierandel

Dualog AS

18,9%

Lofitorsk

13,8%

Orthogenics AS

12,8%

ObexCode AS

10,7%

Pro Bio Group AS

9,8%

Lytix Biopharma AS

5%

Calanus AS

11,9%

Scan Aqua AS

14,6%

Advanced Biopolymers

13,7%

Aranica AS

30%

Northern Biolab AS

10%

Prophylix Pharma AS

13,3%

Taco Scientific AS

20,8%

Infrastrukturinvesteringer Eierandel

Origo Nord AS

20,9%

Forskningsparken Narvik AS

24,9%

Norinnova Invest AS

20,7%

Norinnova Forvaltning AS

20,0%

Såkorninvest Nord AS, Bodø

15,1%

Forskningsparken Møtesenter AS

88,7%

Solgte bedrifter Eierandel

Marin Lipids AS

17,3%

Marin Fisk Holding AS

21,3%

ProBio Nutraceuticals AS

8,3%

TosLab AS

12,0%

Olivita AS

26,7%

mPower AS

20,0%

Well Diagnostics AS

14,7%

Arena Norge AS

7,1%

Fisknett AS

20%

Invenia iLab AS

< 1%

Norinnova er involvert i en rekke prosjekter / bedrifter gjennom Forny programmet.